The Dark Side of “Smart Drugs”: Cognitive Enhancement vs. Clinical Concerns
Abstract The European Union Drugs Agency has emphasized the increasing difficulty in monitoring the drug market due to the emergence…
neuropharmacological effects
Evidence-Based Review on Symptomatic Management of Huntington’s Disease
Abstract Huntington’s disease (HD) is a neurodegenerative disorder characterized by motor, behavioral, and cognitive impairments and significant impacts on patient…
Where we live matters: a comparison of chronic pain treatment between remote and non-remote regions of Quebec, Canada
Abstract Objective: Where a person lives is a recognized socioeconomic determinant of health and influences healthcare access. This study aimed…